AU2001276956A1 - Macrocyclic mri contrast agents - Google Patents

Macrocyclic mri contrast agents

Info

Publication number
AU2001276956A1
AU2001276956A1 AU2001276956A AU7695601A AU2001276956A1 AU 2001276956 A1 AU2001276956 A1 AU 2001276956A1 AU 2001276956 A AU2001276956 A AU 2001276956A AU 7695601 A AU7695601 A AU 7695601A AU 2001276956 A1 AU2001276956 A1 AU 2001276956A1
Authority
AU
Australia
Prior art keywords
macrocyclic
contrast agents
mri contrast
mri
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001276956A
Other languages
English (en)
Inventor
Timothy J. Hubin
Thomas J Meade
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
California Institute of Technology CalTech
Original Assignee
California Institute of Technology CalTech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by California Institute of Technology CalTech filed Critical California Institute of Technology CalTech
Publication of AU2001276956A1 publication Critical patent/AU2001276956A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
AU2001276956A 2000-07-17 2001-07-17 Macrocyclic mri contrast agents Abandoned AU2001276956A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21858100P 2000-07-17 2000-07-17
US60/218,581 2000-07-17
PCT/US2001/022491 WO2002006287A2 (en) 2000-07-17 2001-07-17 Macrocyclic mri contrast agents

Publications (1)

Publication Number Publication Date
AU2001276956A1 true AU2001276956A1 (en) 2002-01-30

Family

ID=22815661

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001276956A Abandoned AU2001276956A1 (en) 2000-07-17 2001-07-17 Macrocyclic mri contrast agents

Country Status (3)

Country Link
US (1) US6656450B2 (US06656450-20031202-C00009.png)
AU (1) AU2001276956A1 (US06656450-20031202-C00009.png)
WO (1) WO2002006287A2 (US06656450-20031202-C00009.png)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6770261B2 (en) * 1995-06-02 2004-08-03 Research Corporation Technologies Magnetic resonance imaging agents for the detection of physiological agents
EP1032430A2 (en) 1997-11-17 2000-09-06 Research Corporation Technologies, Inc. Magnetic resonance imaging agents for the detection of physiological agents
US7067111B1 (en) * 1999-10-25 2006-06-27 Board Of Regents, University Of Texas System Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
US20040146463A1 (en) * 2000-05-04 2004-07-29 Meade Thomas J. Functional MRI agents for cancer imaging
DK1286704T3 (da) 2000-06-02 2014-09-22 Univ Texas Ethylendicystein (EC)-glucose analoge konjugater
JP2004509924A (ja) * 2000-09-25 2004-04-02 ザ、プロクター、エンド、ギャンブル、カンパニー Ｍｒｉ画像増強組成物
US20030004236A1 (en) * 2001-04-20 2003-01-02 Meade Thomas J. Magnetic resonance imaging agents for detection and delivery of therapeutic agents and detection of physiological substances
US20020197648A1 (en) * 2001-05-02 2002-12-26 Silva Robin M. High throughput screening methods using magnetic resonance imaging agents
US20030198597A1 (en) * 2002-04-22 2003-10-23 Meade Thomas J. Novel macrocyclic activatible magnetic resonance imaging contrast agents
FR2856063B1 (fr) * 2003-06-13 2005-10-07 Air Liquide Procede de preparation du cis-8b-methyldecahydro-2a,4a,6a, 8a-tetraazacyclopenta[fg]acenaphthylene,ou du cis-decahydro-2a,4a,6a,8a-tetraazacyclopenta[fg] acenaphthylene, du cyclene, et de cyclenes fonctionnalises
US9050378B2 (en) 2003-12-10 2015-06-09 Board Of Regents, The University Of Texas System N2S2 chelate-targeting ligand conjugates
US20060088475A1 (en) * 2004-05-10 2006-04-27 Northwestern University Self-immolative magnetic resonance imaging contrast agents sensitive to beta-glucuronidase
US7306785B2 (en) * 2004-09-23 2007-12-11 General Electric Company Multifunctional cross-bridged tetraaza macrocyclic compounds and methods of making and using
US8758723B2 (en) * 2006-04-19 2014-06-24 The Board Of Regents Of The University Of Texas System Compositions and methods for cellular imaging and therapy
US8834840B1 (en) 2006-10-04 2014-09-16 Northwestern University Magnetic resonance imaging of self-assembled biomaterial scaffolds
US10925977B2 (en) 2006-10-05 2021-02-23 Ceil>Point, LLC Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
WO2009036441A2 (en) * 2007-09-14 2009-03-19 Northwestern University Contrast agents
US8580231B2 (en) 2008-05-23 2013-11-12 Northwestern University Compositions and methods comprising magnetic resonance contrast agents
US20100029909A1 (en) * 2008-05-23 2010-02-04 Northwestern University Compositions and methods comprising magnetic resonance contrast agents
US20120095185A1 (en) * 2010-09-20 2012-04-19 Nordion (Canada) Inc. Process for chelating copper ions using cb-te2a bifunctional chelate

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3919102A (en) 1971-03-16 1975-11-11 Henkel & Cie Gmbh Composition and method for activating oxygen utilizing N-acylated tetraaza-bicyclo-nonandiones
US4637988A (en) 1981-07-01 1987-01-20 Eastman Kodak Company Fluorescent labels for immunoassay
US4837169A (en) 1981-07-01 1989-06-06 Eastman Kodak Company Polypyridine Fluorescent labels for immunoassay
US4647447A (en) 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
US5188816A (en) 1984-10-18 1993-02-23 Board Of Regents, The University Of Texas System Using polyazamacrocyclic compounds for intracellular measurement of metal ions using MRS
US4678667A (en) 1985-07-02 1987-07-07 501 Regents of the University of California Macrocyclic bifunctional chelating agents
EP0247156B1 (en) 1985-11-18 1993-06-23 Access Pharmaceuticals Inc. Polychelating agents for image and spectral enhancement (and spectral shift)
US4885363A (en) 1987-04-24 1989-12-05 E. R. Squibb & Sons, Inc. 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
US4877872A (en) 1986-06-24 1989-10-31 The University Of Toledo Production and use of dimers of hematoporophyrin, purpurins, chlorines and purpurin- and chlorin-complexes
US5219553A (en) 1986-08-04 1993-06-15 Salutar, Inc. Composition of a n-carboxymethylated tetraazacyclododecane chelating agent, a paramagnetic metal and excess calcium ions for MRI
US5338532A (en) 1986-08-18 1994-08-16 The Dow Chemical Company Starburst conjugates
FR2604092B1 (fr) 1986-09-19 1990-04-13 Immunotech Sa Immunoreactifs destines a cibler les cellules animales pour leur visualisation ou leur destruction in vivo
US4822594A (en) 1987-01-27 1989-04-18 Gibby Wendell A Contrast enhancing agents for magnetic resonance images
HU208947B (en) 1987-07-16 1994-02-28 Nycomed As Diagnostical compositions and process for producing aminopolycarboxylic acids, their derivatives and metal-kelates
US5531978A (en) 1987-07-16 1996-07-02 Nycomed Imaging As Aminopolycarboxylic acids and derivatives thereof
US5162509A (en) 1989-03-06 1992-11-10 Board Of Regents, The University Of Texas System Process for preparing expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles
US5364613A (en) 1989-04-07 1994-11-15 Sieving Paul F Polychelants containing macrocyclic chelant moieties
US5914095A (en) 1989-04-07 1999-06-22 Salutar, Inc. Polychelants containg amide bonds
US5554748A (en) 1989-04-07 1996-09-10 Nycomed Salutar, Inc. Adducts of macrocyclic chelants
US5230883A (en) 1989-05-04 1993-07-27 Wisconsin Alumni Research Foundation Method for localization and treatment of tumors using polylysine complexes
US5087440A (en) 1989-07-31 1992-02-11 Salutar, Inc. Heterocyclic derivatives of DTPA used for magnetic resonance imaging
US5332567A (en) 1989-08-24 1994-07-26 Immunomedics Detection and treatment of infections with immunoconjugates
US5446145A (en) 1990-01-19 1995-08-29 Nycomed Salutar, Inc. Polychelant compounds
WO1991010669A1 (en) 1990-01-19 1991-07-25 Cockbain, Julian, Roderick, Michaelson Chelating compounds
US5095099A (en) 1990-12-10 1992-03-10 E. I. Du Pont De Nemours And Company Fluorescent compounds for absorption and re-emission of radiation
US5310539A (en) 1991-04-15 1994-05-10 Board Of Regents, The University Of Texas System Melanin-based agents for image enhancement
WO1992019264A1 (en) 1991-05-01 1992-11-12 University Of New Mexico Biomodulators as universal imaging agents
AU660033B2 (en) 1991-05-23 1995-06-08 Imarx Pharmaceutical Corp. Liposoluble compounds for magnetic resonance imaging
US5133956A (en) 1991-05-30 1992-07-28 The Dow Chemical Company Radiolabeled metal-binding protein for the treatment of arthritis
US5262532A (en) 1991-07-22 1993-11-16 E.R. Squibb & Sons, Inc. Paramagnetic metalloporphyrins as contrast agents for magnetic resonance imaging
US5565552A (en) 1992-01-21 1996-10-15 Pharmacyclics, Inc. Method of expanded porphyrin-oligonucleotide conjugate synthesis
DK0655950T3 (da) 1992-08-06 1996-11-18 Smithkline Beecham Plc Chirale katalysatorer og epoxidationsreaktioner katalyseret derved
WO1994004485A1 (en) 1992-08-19 1994-03-03 Mallinckrodt Medical, Inc. LIGANDS FOR Ga-68 PET HEART APPLICATIONS
US5407657A (en) 1992-09-22 1995-04-18 Unger; Evan C. Hybrid magnetic resonance contrast agents
US5466439A (en) 1992-11-12 1995-11-14 Magnetic Research, Inc. Polymeric contrast enhancing agents for magnetic resonance images
US5358704A (en) 1993-09-30 1994-10-25 Bristol-Myers Squibb Hepatobiliary tetraazamacrocyclic magnetic resonance contrast agents
US5417959A (en) 1993-10-04 1995-05-23 Mallinckrodt Medical, Inc. Functionalized aza-crytand ligands for diagnostic imaging applications
EP0661279B1 (fr) 1993-12-30 2001-03-07 Guerbet Ligands polyaminés, complexes métalliques, procédé de préparation, applications diagnostiques et thérapeutiques
US5554749A (en) 1994-01-14 1996-09-10 Mallinckrodt Medical, Inc. Functionalized macrocyclic ligands for imaging applications
AU1681795A (en) 1994-01-14 1995-08-01 Mallinckrodt Medical, Inc. Functionalized aza-macrobicyclic ligands for imaging applications
AU1694895A (en) 1994-01-28 1995-08-15 Mallinckrodt Medical, Inc. Functionalized aza-bimacrocyclic ligands for imaging applications
DE4403789A1 (de) 1994-02-03 1995-08-10 Schering Ag Mittel zur visuellen Markierung von Körpergewebe
WO1995027705A1 (en) 1994-04-08 1995-10-19 Bracco International B.V. Aromatic amide compounds and metal chelates thereof
GB9407812D0 (en) 1994-04-20 1994-06-15 Nycomed Salutar Inc Compounds
US6693190B1 (en) 1994-05-11 2004-02-17 Bracco International B.V. Enhanced relaxivity monomeric and multimeric compounds
IT1269839B (it) 1994-05-26 1997-04-15 Bracco Spa Coniugati di acidi biliari, loro derivati con complessi metallici e relativi usi
US5622821A (en) 1994-06-29 1997-04-22 The Regents Of The University Of California Luminescent lanthanide chelates and methods of use
DE4428874A1 (de) 1994-08-08 1996-02-22 Schering Ag Dimere DTPA-Derivate und deren Metallkomplexe, diese Komplexe enthaltende pharmazeutische Mittel, deren Verwendung in der Diagnostik und Therapie sowie Verfahren zur Herstellung der Komplexe und Mittel
TW319763B (US06656450-20031202-C00009.png) 1995-02-01 1997-11-11 Epix Medical Inc
US5955605A (en) 1995-02-21 1999-09-21 Neorx Corporation Biotinidase resistant biotin-DOTA conjugates
US5707605A (en) 1995-06-02 1998-01-13 Research Corporation Technologies Magnetic resonance imaging agents for the detection of physiological agents
US5980862A (en) 1995-06-02 1999-11-09 Research Corporation Technologies Magnetic resonance imaging agents for the detection of physiological agents
EP1382332A1 (en) 1995-06-26 2004-01-21 Chelator LLC Method for inhibiting bacterial or fungal growth using a polyamine derivative as complexing agent
AU720841B2 (en) 1995-12-12 2000-06-15 California Institute Of Technology Cobalt schiff base compounds
IT1283218B1 (it) 1996-03-08 1998-04-16 Bracco Spa Polichelanti, loro complessi con ioni metallici, loro preparazione e loro usi
CN1108824C (zh) 1996-04-01 2003-05-21 Epix医学公司 生物活化的诊断成像造影剂
AU750686B2 (en) 1997-10-27 2002-07-25 Research Corporation Technologies, Inc. Magnetic resonance imaging agents for the delivery of therapeutic agents
US6093382A (en) 1998-05-16 2000-07-25 Bracco Research Usa Inc. Metal complexes derivatized with folate for use in diagnostic and therapeutic applications
BR0013171A (pt) 1999-07-29 2002-05-28 Epix Medical Inc Agentes multimericos para formação de imagem de objetivação através de ligação multi-local
WO2001052906A2 (en) 2000-01-22 2001-07-26 Epix Medical, Inc. Magnetic resonance imaging using contrast agents prodrugs bioactivated by enzymatic cleavage

Also Published As

Publication number Publication date
WO2002006287A9 (en) 2002-07-18
US6656450B2 (en) 2003-12-02
WO2002006287A3 (en) 2002-10-17
US20020049308A1 (en) 2002-04-25
WO2002006287A2 (en) 2002-01-24

Similar Documents

Publication Publication Date Title
AU2001249597A1 (en) Low-field mri
AU2002213152A1 (en) Mri stent
AU2002225701A1 (en) Integrated magnetic bearing
AU2001276956A1 (en) Macrocyclic mri contrast agents
AU2001247806A1 (en) Endoluminal mri probe
AU2001288040A1 (en) Homeostasis-maintaining agents
AU2001251441A1 (en) Macrocyclic chelants for metallopharmaceuticals
AU2002214284A1 (en) Anti-helicobacterial agents
AU2000228235A1 (en) Resonance shifting
AUPQ886100A0 (en) Diagnostic test
AU2002241576A1 (en) Paramagnetic metal ion-based macrocyclic contrast agents
AU2002231676A1 (en) Triazolopyrimidines
EP1151667A3 (en) Plant-activating agent
AU2002221895A1 (en) Macrolide solvates
AU5981599A (en) Mri contrast agent
AU2001223813A1 (en) Personalized hardware
AU2001236100A1 (en) Vasoactive agents
AU2001236968A1 (en) Lssd interface
AU2002214839A1 (en) Seat
AU2002234567A1 (en) Console
AU2529501A (en) Macrocyclic compounds and their use
AU2001278714A1 (en) Vascular relaxation agents
AU2002215180A1 (en) Beta-lactam antibiotic-polysaccharide complex
AU2001274683A1 (en) Contrast agents
AU2002222344A1 (en) Triazolopyrimidines